Pipequaline

    • Catalog No.:MC1376
    • Description
    • CasNo:
    • 77472-98-1
    • MolecularFormula:
    • C22H24N2
    • Purity:
    • >98%
    • Target:
    • GABA Receptor
    • IC50:
    • No data
    • In Vitro:
    • Pipequaline is extensively bound to plasma proteins: i.e. human serum albumin (HSA), alpha-1-acid gl
    • In Vivo:
    • Intravenously administered pipequaline exerts a partial suppression of activations by kainate, gluta
    • Fields:
    • Pipequaline (PK 8165) is a partial benzodiazepine receptor agonist with anxiolytic activity.
    • Specificity:
    • Target: GABA Receptor. Fields: Pipequaline (PK 8165) is a partial benzodiazepine receptor agonist with anxiolytic activity.
    • Concentration:
    • >98%
    • Storage Stability:
    • 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
    • Other Name:
    • PK-8165; PK8165; PK 8165
    • MolecularWeight(Da):
    • 316.44
    • References:
    • [1]. Essassi D, et al. Pipequaline transport from blood to brain and liver: role of plasma protein-bound drug. J Pharm Pharmacol. 1989 Sep;41(9):595-600. [2]. Debonnel G, et al. Pipequaline acts as a
    • Products Images